The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1123
https://www.valueinhealthjournal.com/article/S1098-3015(13)03028-3/fulltext
Title :
The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03028-3&doi=10.1016/j.jval.2013.08.1123
First page :
A498
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
976